Macrogenics (MGNX) Change in Accured Expenses (2012 - 2026)

Macrogenics (MGNX) has 15 years of Change in Accured Expenses data on file, last reported at -$3.7 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$3.7 million, down 219.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.4 million (down 158.54% YoY), and the FY2025 annual result was -$6.8 million, down 499.65% from the prior year.
• Change in Accured Expenses climbed to -$3.7 million in Q1 2026 per MGNX's latest filing, from -$7.8 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $12.7 million in Q3 2022 and troughed at -$12.4 million in Q2 2022.
• A 5-year average of -$1.1 million and a median of -$1.1 million in 2023 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 8575.0% in 2024, then soared 567.5% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at -$4.5 million in 2022, then soared by 67.78% to -$1.4 million in 2023, then jumped by 207.32% to $1.5 million in 2024, then tumbled by 603.57% to -$7.8 million in 2025, then jumped by 52.04% to -$3.7 million in 2026.
• Business Quant data shows MGNX's Change in Accured Expenses at -$3.7 million in Q1 2026, -$7.8 million in Q4 2025, and $1.3 million in Q3 2025.